loader image

LATVIAN

BIOMEDICAL

RESEARCH AND STUDY CENTRE


RESEARCH AND EDUCATION IN BIOMEDICINE FROM GENES TO HUMAN

Project Title: Exploring the molecular mechanisms behind the effects of physical exercise on breast cancer prevention (CancerBeat)

Funding: EEA and Norway Grants 2014-2021

Project No EEA-RESEARCH-164

Period:01.05.2021-30.04.2024

Project promoter: Latvian Biomedical Research and Study Centre

Partners:  Oslo University Hospital; National Institute of Chemical Physics and Biophysics, Estonia; National Cancer Institute, Lithuania; Latvian Academy of Sport Education

Project Costs: EUR 1 000 000.00

Principle Investigator: Dr. Bio. Aija Linē

Project aim (summary): It is well known that physical activity can prevent cancer development, but the molecular mechanisms behind these effects are poorly understood. During exercise, extracellular vesicles (EVs) are released into the circulation and mediate tissue crosstalk with potential effects on tumour cells and the immune tumour microenvironment. The overall aim of CancerBeat is to characterise the molecular cargo of exercise-induced EVs and explore their effects on breast cancer (BC) progression in vitro and in vivo.

Expected results of the project: It is planned to prepare 8 scientific publications, to present the results at 9 international conferences during the project.

More information on EEA and Norwegian grants is available at: www.norwaygrants.lv un www.eeagrants.lv.

Programme: Research and Education, Baltic research Programme

Information published 05.05.2021.

Progress of the project

1 May 2021 – 31 July 2021

The study protocol was approved by the Ethics committee of LASE and the enrolment of healthy female endurance runners has been started. Participants undertook an exercise protocol consisting of a submaximal physical fitness test at LASE Health Research in Sports lab and the blood samples were collected before and immediately after the exercise. Extracellular vesicles (EVs) were isolated from the blood samples at the BMC.

Information published 30.07.2021.

Progress of the project

1 August 2021 – 31 October 2021

The enrolment of healthy female long-distance runners has been completed. A total of 19 runners were involved. To assess the reproducibility, for 12 participants, sampling was repeated twice. Next, the EV preparations will be subjected to RNA sequencing and proteomics analyses and functional experiments in BC cell cultures at OUH and BMC. NCI has performed a pilot physical activity study in two mice strains, which will allow a large-scale study aiming to elucidate the effects of exercise-induced EVs on the immune tumour microenvironment and progression of metastatic cancer using a mouse model of breast cancer in a therapeutic and prophylactic setting. NICPB has optimized breast cancer cell culture growth conditions in a serum-free medium to investigate the influence of exercise-induced EVs on energy metabolism.

Information published 29.10.2021.

Progress of the project

1 November 2021 – 31 January 2022

We have started to analyse the RNA content of EVs isolated from blood samples of healthy long-distance runners collected before and immediately after the run. Preliminary results revealed a number of differentially expressed genes both between pre-run and post-run samples and between pre-run samples of runners and physically inactive controls. The differences between pre-run and post-run samples reflect the acute reaction to physical exercise, whereas the differences between the runners and controls reflect the long-term adaptation to exercise. Currently, we are studying the differentially expressed genes in order to identify the cell types that produce EVs during the exercise and to get an insight into the molecular processes triggered by the exercise.

Information published 31.01.2022.

Progress of the project

1 February 2022 – 30 April 2022

The clinical study protocol has been approved by CMĒK and the recruitment of breast cancer patients has been started. We invite stage II-III breast cancer patients to whom neoadjuvant chemotherapy has been prescribed to participate in this study. Based on the physical capacity measurements, a personalised training program is designed for each participant and we encourage the patients to carry out the program for the whole duration of the chemotherapy. The pre- and post-exercise blood samples will be collected twice during the study – before the onset of chemotherapy and after the final course of chemotherapy. EVs are isolated from the blood samples and next they will be subjected to the analysis of their RNA and protein cargo as well as for studying the functional effects they elicit in breast cancer cells.

Information published 29.04.2022.

Progress of the project

1 May 2022 – 31 July 2022

Recruitment of breast cancer patients is continued. The first patients have already completed the training program and the second set of blood samples is collected from these patients. We have isolated EVs from the blood samples and started to study their molecular content. Furthermore, we have started to study the effects of exercise-induced EVs on the transcriptome of breast cancer cells. The first results of this project were presented at FEBS3+ meeting in Tallinn.

Information published 29.07.2022.